WCCT at ARVO 2019 Exhibition

WCCT will be participating in ARVO 2019 from April 28th – May 1st, and will be exhibiting at Booth 1550. We’ll have business development and clinical operations personnel, as well as some of our partner ophthalmology investigators and research sites available to discuss our early clinical development capabilities in the areas of dry eye, glaucoma, uveitis and various retinal diseases.

The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) attracts over 11,000 attendees from over 75 countries, and currently stands as the largest gathering of eye and vision researchers in the world. The conference takes place in Vancouver, BC from April 28 – May 2, 2019, and brings together scientists, drug and device developers, and medical practitioners from all over the world to gain insight on the latest trends and innovations in the industry.  The meeting provides timely information and sharing opportunities that help the community at large to better understand, treat, and prevent disorders of the visual system. We’re excited to participate in the various informative sessions to garner new insights, and we’re looking forward to sharing valuable information and making lasting connections with others in attendance.

To schedule a time to speak, please contact us. We’ll be happy to provide additional information and answer any questions you might have. We look forward to seeing you there.

ABOUT US

Since 1998, WCCT Global has been conducting clinical research in all phases and across a number of therapeutic areas, with an emphasis in designing and overseeing early clinical development programs. Currently, WCCT owns and operates one of the largest Phase 1 clinical pharmacology units in the United States, and is an industry-leader in conducting Asian bridging studies, specifically in Japanese volunteers, aiding the development of treatments for the global drug market. In addition to running Phase 1 trials in healthy volunteers and Asian bridging studies, WCCT offers a full suite of contract research and clinical support services, and is the only US-based clinical research organization capable of conducting viral challenge studies at its stateside facility.

CONTACT US:

Website: Click here.

salvador.solis@wcct.com